MA 09.11 Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) – a feasibility study

Haslett, K., Bayman, N., Franks, K. et al. (11 more authors) (2017) MA 09.11 Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) – a feasibility study. In: Journal of Thoracic Oncology. IASLC 18th World Conference on Lung Cancer, 15-18 Oct 2017, Yokohama, Japan. Elsevier , S1838-S1839.

Metadata

Authors/Creators:
  • Haslett, K.
  • Bayman, N.
  • Franks, K.
  • Groom, N.
  • Hanna, G.
  • Harden, S.
  • Harris, C.
  • Harrow, S.
  • Hatton, M.
  • Mccloskey, P.
  • Mcdonald, F.
  • Ashcroft, L.
  • Ryder, D.
  • Faivre-Finn, C.
Copyright, Publisher and Additional Information: © 2017 Elsevier.
Keywords: Personalized; Intensification; Radiotherapy
Dates:
  • Published (online): 7 November 2017
  • Published: 7 November 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 23 Mar 2020 10:04
Last Modified: 23 Mar 2020 10:04
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jtho.2017.09.532
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics